1. Histone deacetylases and acetylated histone H3 are involved in the process of hepatitis B virus DNA replication
   Di Zhang et al, 2019, Life Sciences CrossRef
2. Modulations of Histone Deacetylase 2 Offer a Protective Effect through the Mitochondrial Apoptosis Pathway in Acute Liver Failure
   Yao Wang et al, 2019, Oxidative Medicine and Cellular Longevity CrossRef
3. Increase in HDAC9 suppresses myoblast differentiation via epigenetic regulation of autophagy in hypoxia
   Zhang Zhang et al, 2019, Cell Death Dis CrossRef
4. Role of histone acetylation and DNA methylation in hepatic inflammatory response
   Yao Wang et al, 2019, WCJD CrossRef
5. Histone deacetylases in virus‐associated cancers
   Habibollah Mirzaei et al, 2019, Rev Med Virol CrossRef
6. Stimulation of toll-like receptor 4 downregulates the expression of α7 nicotinic acetylcholine receptors via histone deacetylase in rodent microglia
   Yoki Nakamura et al, 2020, Neurochemistry International CrossRef
7. TNF‐α/HMGB1 inflammation signalling pathway regulates pyroptosis during liver failure and acute kidney injury
   Yao Wang et al, 2020, Cell Prolif CrossRef
8. Sodium acetate-mediated inhibition of histone deacetylase alleviates hepatic lipid dysregulation and its accompanied injury in streptozotocin-nicotinamide-induced diabetic rats
   Kehinde S. Olaniyi et al, 2020, Biomedicine & Pharmacotherapy CrossRef
9. Updating a Strategy for Histone Deacetylases and Its Inhibitors in the Potential Treatment of Cerebral Ischemic Stroke
   Yuzhen Xu et al, 2020, Disease Markers CrossRef
10. Synergistic Enhancement of Cancer Therapy Using HDAC Inhibitors: Opportunity for Clinical Trials
    Lourdes Hontecillas-Prieto et al, 2020, Front. Genet. CrossRef
11. HDAC Inhibition Increases HLA Class I Expression in Uveal Melanoma
    Zahra Souri et al, 2020, Cancers CrossRef
12. Nuclear oligo hashing improves differential analysis of single-cell RNA-seq
    Hyeon-Jin Kim et al, 2022, Nat Commun CrossRef
13. Bilirubin and Epigenetic Modifications in Metabolic and Immunometabolic Disorders
    Mostafa Moradi Sarabi et al, 2022, EMIDDT CrossRef
14. Characteristics and mechanisms of latency-reversing agents in the activation of the human immunodeficiency virus 1 reservoir
    Zhujiao Zhou et al, 2023, Arch Virol CrossRef
15. HDAC inhibitors: Promising agents for leukemia treatment
    Yun Deng et al, 2023, Biochemical and Biophysical Research Communications CrossRef
16. null
    Atanu Mondal et al, 2024 CrossRef